Tagged: Global One Health

The Global One Health (GOH), LLC provided training for field supervisors and data collectors of the measles five-dose vaccination vial survey. The survey was designed to assess the effect of two interventions that may help address health workers' reluctance to open 10-dose measles vaccination vials. 

Zemichael Gizaw Workneh, a PhD fellow supported by the Global One Health initiative (GOHi) through the One Health Eastern Africa Research Training (OHEART) Program, successfully defended his PhD dissertation entitled “Fecal indicator bacteria along multiple environmental transmission pathways (water, food, hands, and soil), intestinal parasites, environmental enteric dysfunction,

Leuel Lisanwork graduated with his Doctor of Medicine from Bahir Dar University in Ethiopia in 2016. After graduating, he joined Ambo University as a lecturer and general practitioner.

As part of the International Health Regulation (IHR) implementation, the Global One Health initiative (GOHi) established four regional influenza molecular laboratories in Adama, Bahir Dar, Addis Ababa and Arbaminch in Ethiopia through the U.S. Centers for Disease Control Coronavirus Aid, Relief and Economic Security (CARES) Act. 

The Global One Health (GOH) LLC provided training for surveillance officers and data clerks through the Hospital Based Sentinel Surveillance of Adverse Events of Special Interest (AESI) project in Ethiopia from May 4-6 in collaboration with the Ethiopian Food and Drug Authority, U.S. Centers for Disease Control and the Taskforce for Global Health. 

Chairman of the Kenya Medical Research Institute (KEMRI) Board of Directors, Daniel Mbinda, Board Members George Njoroge and Timothy Waema and the acting Director General for KEMRI, Sam Kariuki, visited The Ohio State University on May 5 and 6 to discuss current and future collaborations.

Executive Director of Ohio State's Global One Health initiative, Wondwossen Gebreyes, recently visited the U.S. Embassy in Ethiopia and met with U.S. Ambassador to Ethiopia Tracey Ann Jacobson, USAID Ethiopia Director Sean Jones, CDC Country Director for Ethiopia Caroline Ryan, and Cultural Attaché Doug Johnston to discuss strategic priorities and strengthen long-standing partnerships in the health and higher education sectors.

The delegation also included Ebba Abate, Desalegne Degefaw and Bethlehem Hailemariam from the GOHi Eastern Africa office.

In collaboration with the U.S. Centers for Disease Control (CDC) and the Ethiopian Public Health Institute (EPHI), the Global One Health initiative (GOHi) has been conducting a vaccine-preventable disease (VPD) surveillance costing study in Ethiopia.

This cross-sectional, retrospective, quantitative study was conducted at five administrative levels – federal, regional, zonal, woreda and health facilities – to collect primary and secondary data on resource utilization and costs from selected costing centers over one year.

The Ohio State Global One Health LLC supported the Ethiopian Food and Drug Authority (EFDA) to undertake a causality assessment of adverse events following COVID-19 vaccines reported to the pharmacovigilance system. Experts from the national pharmacovigilance advisory committee, the EFDA pharmacovigilance team and 26 clinicians conducted the assessment.

The Global One Health initiative (GOHi) Eastern Africa office, in collaboration with Ethiopian Public Health Institute (EPHI), facilitated a three-day training from March 2-4 at Bishoftu, Ethiopia, targeting monitoring and evaluation (M&E) at EPHI and sub nationals working with the surveillance program. The training covered M&E basics, M&E frameworks, public health evaluations, stakeholder engagement, SMART indicators and data quality and use with a focus on designing and planning M&E systems to improve project outcomes and data-driven actions.